PharmaCorp Rx Inc
XTSX:PCRX
PharmaCorp Rx Inc
XTSX:PCRX
Price:
0.425
CAD
-5.56%
Market Closed
Market Cap:
CA$74m
Cash Flow Statement
Cash Flow Statement
PharmaCorp Rx Inc
PharmaCorp Rx Inc
Currency: CAD
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
(1)
|
(1)
|
(0)
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
1
|
|
| Change in Deffered Taxes |
(0)
|
(0)
|
(0)
|
(0)
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
(0)
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
(0)
|
|
| Change in Working Capital |
1
|
0
|
0
|
1
|
|
| Cash from Operating Activities |
0
N/A
|
0
+255%
|
0
-7%
|
2
+288%
|
|
| Investing Cash Flow | |||||
| Capital Expenditures |
(0)
|
(0)
|
(2)
|
(0)
|
|
| Other Items |
(17)
|
0
|
(18)
|
(26)
|
|
| Cash from Investing Activities |
(17)
N/A
|
(17)
0%
|
(20)
-19%
|
(26)
-30%
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
27
|
0
|
8
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
3
|
|
| Other |
0
|
0
|
0
|
(0)
|
|
| Cash from Financing Activities |
27
N/A
|
27
0%
|
7
-73%
|
3
-61%
|
|
| Change in Cash | |||||
| Net Change in Cash |
11
N/A
|
11
+2%
|
(12)
N/A
|
(22)
-77%
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
0
N/A
|
0
+247%
|
(2)
N/A
|
2
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
